Alterity Therapeutics Files 6-K, Incorporates by Reference
Ticker: PRNAF · Form: 6-K · Filed: Apr 9, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-update, registration-statement, substantial-holder
TL;DR
Alterity Therapeutics 6-K filed: substantial holder update, incorporated into S-8/F-3 filings.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on April 9, 2025, to incorporate by reference into its existing Registration Statements on Form S-8 and Form F-3. The filing includes an exhibit titled "Becoming a substantial holder."
Why It Matters
This filing indicates a change in substantial shareholding, which could signal shifts in investor confidence or strategic direction for Alterity Therapeutics.
Risk Assessment
Risk Level: low — The filing is primarily administrative, incorporating previous documents into registration statements, with no new financial or operational disclosures.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Registrant
- April 9, 2025 (date) — Filing date
- Form S-8 (document) — Incorporated by reference
- Form F-3 (document) — Incorporated by reference
- Becoming a substantial holder (document) — Exhibit title
FAQ
What is the purpose of this Form 6-K filing by Alterity Therapeutics Ltd.?
The Form 6-K is being filed to incorporate by reference into Alterity Therapeutics Ltd.'s existing Registration Statements on Form S-8 and Form F-3.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is April 9, 2025.
What exhibit is included with this Form 6-K filing?
The filing includes Exhibit 99.1, titled "Becoming a substantial holder."
Which registration statements is this 6-K being incorporated into?
This 6-K is being incorporated by reference into Alterity Therapeutics Ltd.'s Registration Statements on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076).
What was Alterity Therapeutics Ltd. formerly known as?
Alterity Therapeutics Ltd. was formerly known as PRANA BIOTECHNOLOGY LTD.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 9, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).